Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Trellus Health. (TRLS) Share Price

Price 0.40p on 02-01-2026 at 19:10:09
Change 0.025p 6.67%
Buy 0.45p
Sell 0.35p
Last Trade: Buy 250,000.00 at 0.4225p
Day's Volume: 1,562,518
Last Close: 0.40p
Open: 0.375p
ISIN: GB00BNNFM402
Day's Range 0.375p - 0.40p
52wk Range: 0.35p - 4.95p
Market Capitalisation: £646.03k
VWAP: 0.385558p
Shares in Issue: 161.51m

Trellus Health. (TRLS) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 250,000 0.4225p Ordinary
11:19:55 - 02-Jan-26
Buy* 90,000 0.4248p Ordinary
11:02:24 - 02-Jan-26
Sell* 567,275 0.362p Ordinary
10:16:44 - 02-Jan-26
Sell* 160,000 0.371p Ordinary
09:49:11 - 02-Jan-26
Buy* 91,153 0.429p Ordinary
09:29:35 - 02-Jan-26
Sell* 2,919 0.35p SI Trade
08:43:11 - 02-Jan-26
Buy* 266,391 0.395p Ordinary
08:42:52 - 02-Jan-26
Sell* 300,000 0.385p Ordinary
12:19:45 - 31-Dec-25
Unknown* 1,455,731 0.38p Ordinary
12:18:20 - 31-Dec-25
Unknown* -1,450,000 0.38p Ordinary
Correction
12:18:20 - 31-Dec-25
See more Trellus Health. trades

Trellus Health. (TRLS) Share Price History

Time period:
to
Date Open High Low Close Volume
2nd Jan 2026 (Fri) 0.375 0.40 0.375 0.40 1,562,518
1st Jan 2026 (Thu) 0.375 0.375 0.375 0.375 0
31st Dec 2025 (Wed) 0.55 0.55 0.35 0.375 10,048,764
30th Dec 2025 (Tue) 0.55 0.55 0.55 0.55 1,000
29th Dec 2025 (Mon) 0.55 0.55 0.55 0.55 50,042
26th Dec 2025 (Fri) 0.55 0.55 0.55 0.55 0
25th Dec 2025 (Thu) 0.55 0.55 0.55 0.55 0
24th Dec 2025 (Wed) 0.55 0.55 0.55 0.55 182,828
23rd Dec 2025 (Tue) 0.55 0.55 0.55 0.55 1,518
22nd Dec 2025 (Mon) 0.55 0.55 0.55 0.55 109,436
19th Dec 2025 (Fri) 0.55 0.55 0.55 0.55 242,379
18th Dec 2025 (Thu) 0.55 0.55 0.55 0.55 143,438
17th Dec 2025 (Wed) 0.55 0.55 0.55 0.55 2,945
16th Dec 2025 (Tue) 0.55 0.55 0.55 0.55 200,000
15th Dec 2025 (Mon) 0.55 0.55 0.55 0.55 58,262
12th Dec 2025 (Fri) 0.55 0.55 0.55 0.55 870,253
11th Dec 2025 (Thu) 0.55 0.55 0.55 0.55 985
10th Dec 2025 (Wed) 0.55 0.55 0.55 0.55 664
9th Dec 2025 (Tue) 0.55 0.55 0.55 0.55 800
8th Dec 2025 (Mon) 0.55 0.55 0.55 0.55 285
5th Dec 2025 (Fri) 0.55 0.55 0.55 0.55 1,000
See more Trellus Health. price history

Trellus Health. (TRLS) Regulatory News

Date Source Headline
30th Dec 2025 5:00 pm RNS Proposed issue of Secured Convertible Loan Notes
30th Dec 2025 5:00 pm RNS Proposed issue of Secured Convertible Loan Notes
24th Nov 2025 7:00 am RNS Finance update
7th Nov 2025 7:00 am RNS Contract signed with second leading CRO
22nd Oct 2025 7:00 am RNS Contract Signed with Leading Global CRO
21st Oct 2025 7:00 am RNS Company Update
8th Sep 2025 3:15 pm RNS Interim results - Replacement
8th Sep 2025 7:00 am RNS Interim results
3rd Sep 2025 7:00 am RNS Notice of Results
12th Aug 2025 7:00 am RNS Holding(s) in Company
See more Trellus Health. regulatory news

Trellus Health. (TRLS) Share News

Trellus Health shares jump as USD600,000 loan note extends cash runway

24th Nov 2025 11:51

(Alliance News) - Trellus Health PLC on Monday said it has entered into a USD600,000 unsecured loan agreement with its long-standing shareholder, Icahn School of Medicine at Mount Sinai. Read More

Trellus Health hails signing of contract with "leading" research firm

7th Nov 2025 14:17

(Alliance News) - Trellus Health PLC on Friday said it signed a contract with "one of the largest global clinical research organisations". Read More

TRADING UPDATES: Genflow patent progress; Accsys new debt facilities

22nd Oct 2025 22:20

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: Trellus Health reduces cash burn, financing talks continue

21st Oct 2025 19:55

Trellus Health PLC - London-based healthcare company - Says its cash runway now extends to early December, after cost-saving measures cut monthly cash burn to around USD395,000 from USD440,000. Talks continue re a potential equity fundraising to support the next phase of growth but there can be no certainty that any funding transaction will be concluded. No other near-term strategic opportunities have been identified at this time and it is unlikely that any can be identified before early December, Trellus adds. The company remains in late-stage contract talks with a leading global contract research organisation for a mid-stage clinical trial and has secured preferred vendor status with another. It expects to announce at least one new collaboration by the end of November and continues discussions with potential investors over a possible equity fundraising to support its next growth phase. Read More

AIM WINNERS & LOSERS: Eco Buildings wins "landmark" contract in Chile

21st Oct 2025 10:49

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

See more Trellus Health. news
FTSE 100 Latest
Value9,951.14
Change19.76

Login to your account

Forgot Password?

Not Registered